🇺🇸 Metformin, Pioglitazone in United States

39 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Drug Ineffective — 8 reports (20.51%)
  2. Asthenia — 4 reports (10.26%)
  3. Completed Suicide — 4 reports (10.26%)
  4. Diarrhoea — 4 reports (10.26%)
  5. Nausea — 4 reports (10.26%)
  6. Blood Cholesterol Increased — 3 reports (7.69%)
  7. Depression — 3 reports (7.69%)
  8. Dizziness — 3 reports (7.69%)
  9. Dyspnoea — 3 reports (7.69%)
  10. Pain — 3 reports (7.69%)

Source database →

Other Diabetes approved in United States

Frequently asked questions

Is Metformin, Pioglitazone approved in United States?

Metformin, Pioglitazone does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Metformin, Pioglitazone in United States?

Khyber Medical University Peshawar is the originator. The local marketing authorisation holder may differ — check the official source linked above.